CALX Quote, Financials, Valuation and Earnings

Intellinetics has a net margin of -2.17% compared to Calix's net margin of -17.13%. Calix's return on equity of -4.53% beat Intellinetics's return on equity of -10.61%.

Calix has a consensus price target of $49.50, signalling upside risk potential of 4.78%. On the other hand Intellinetics has an analysts' consensus of $16.50 which suggests that it could grow by 42.24%. Given that Intellinetics has higher upside potential than Calix, analysts believe Intellinetics is more attractive than Calix.

Calix has a beta of 1.349, which suggesting that the stock is 34.915% more volatile than S&P 500. In comparison Intellinetics has a beta of 0.525, suggesting its less volatile than the S&P 500 by 47.506%.

Calix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intellinetics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Calix pays -- of its earnings as a dividend. Intellinetics pays out -- of its earnings as a dividend.

Calix quarterly revenues are $220.2M, which are larger than Intellinetics quarterly revenues of $4.2M. Calix's net income of -$4.8M is lower than Intellinetics's net income of -$727.6K. Notably, Calix's price-to-earnings ratio is 605.41x while Intellinetics's PE ratio is 248.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Calix is 3.78x versus 2.85x for Intellinetics. Usually stocks with elevated PS ratios are considered overvalued.

UiPath has a net margin of -2.17% compared to Calix's net margin of -6.33%. Calix's return on equity of -4.53% beat UiPath's return on equity of -3.7%.

Calix has a consensus price target of $49.50, signalling upside risk potential of 4.78%. On the other hand UiPath has an analysts' consensus of $14.13 which suggests that it could grow by 15.44%. Given that UiPath has higher upside potential than Calix, analysts believe UiPath is more attractive than Calix.

Calix has a beta of 1.349, which suggesting that the stock is 34.915% more volatile than S&P 500. In comparison UiPath has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Calix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UiPath offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Calix pays -- of its earnings as a dividend. UiPath pays out -- of its earnings as a dividend.

Calix quarterly revenues are $220.2M, which are smaller than UiPath quarterly revenues of $356.6M. Calix's net income of -$4.8M is higher than UiPath's net income of -$22.6M. Notably, Calix's price-to-earnings ratio is 605.41x while UiPath's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Calix is 3.78x versus 4.68x for UiPath. Usually stocks with elevated PS ratios are considered overvalued.

Signing Day Sports has a net margin of -2.17% compared to Calix's net margin of -568.22%. Calix's return on equity of -4.53% beat Signing Day Sports's return on equity of --.

Calix has a consensus price target of $49.50, signalling upside risk potential of 4.78%. On the other hand Signing Day Sports has an analysts' consensus of -- which suggests that it could fall by --. Given that Calix has higher upside potential than Signing Day Sports, analysts believe Calix is more attractive than Signing Day Sports.

Calix has a beta of 1.349, which suggesting that the stock is 34.915% more volatile than S&P 500. In comparison Signing Day Sports has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Calix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Signing Day Sports offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Calix pays -- of its earnings as a dividend. Signing Day Sports pays out -- of its earnings as a dividend.

Calix quarterly revenues are $220.2M, which are larger than Signing Day Sports quarterly revenues of $148.4K. Calix's net income of -$4.8M is lower than Signing Day Sports's net income of -$843K. Notably, Calix's price-to-earnings ratio is 605.41x while Signing Day Sports's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Calix is 3.78x versus 1.67x for Signing Day Sports. Usually stocks with elevated PS ratios are considered overvalued.

WidePoint has a net margin of -2.17% compared to Calix's net margin of -2.12%. Calix's return on equity of -4.53% beat WidePoint's return on equity of -14.61%.

Calix has a consensus price target of $49.50, signalling upside risk potential of 4.78%. On the other hand WidePoint has an analysts' consensus of $7.50 which suggests that it could grow by 148.34%. Given that WidePoint has higher upside potential than Calix, analysts believe WidePoint is more attractive than Calix.

Calix has a beta of 1.349, which suggesting that the stock is 34.915% more volatile than S&P 500. In comparison WidePoint has a beta of 1.593, suggesting its more volatile than the S&P 500 by 59.32%.

Calix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. WidePoint offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Calix pays -- of its earnings as a dividend. WidePoint pays out -- of its earnings as a dividend.

Calix quarterly revenues are $220.2M, which are larger than WidePoint quarterly revenues of $34.2M. Calix's net income of -$4.8M is lower than WidePoint's net income of -$724.1K. Notably, Calix's price-to-earnings ratio is 605.41x while WidePoint's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Calix is 3.78x versus 0.20x for WidePoint. Usually stocks with elevated PS ratios are considered overvalued.